LiDCO : Directorate Change

LiDCO Group Plc

('LiDCO' or the 'Company')

Directorate Change

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that Jill McGregor, Chief Financial Officer has informed the Board of her intention to leave the Company due to relocating to Scotland for personal reasons. Ms McGregor's notice period is six months and it is currently expected that she will remain in post throughout that period. The Board will commence the process of seeking a successor without delay.

Commenting, Matt Sassone, Chief Executive Officer of LiDCO, said:'We're disappointed to see Jill leave however we understand her decision. I would like to thank Jill for her contribution to the Company over the last 15 months and we all wish her well in the future. We will look to appoint a suitable replacement to assist with our expansion plans as we take advantage of the growth opportunities that we see ahead of us, in particular as we see more customers migrate to our High Usage Programme.'

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For further information, please contact:

LiDCO Group Plc	www.lidco.com
Matt Sassone (CEO)	Tel: [phone]
finnCap	Tel: [phone]
Geoff Nash / Emily Watts (Corporate Finance)
Andrew Burdis (Corporate Broking)
Walbrook PR Ltd	Tel: [phone] [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About LiDCO Group Plc (www.lidco.com)

LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre.

A number of clinical studies have shown that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, originally developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

Key Products:

LiDCOunity:a hemodynamic monitor that combines the full suite of LiDCO technology (non-invasive, minimally invasive and calibrated technologies) into one platform. Designed to have the flexibility to adapt to a patient's changing acuity, the product enables clinicians to seamlessly transition between non-invasive, minimally invasive and calibrated hemodynamic monitoring.LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%).LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anaesthetists to receive accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapidprovides:

· early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

· quantification of hemodynamic response guidance on effective delivery of fluids to ensure the right amount at the right time

The software incorporated into LiDCOrapidallows the LiDCOrapidmonitor to co-display Medtronic's level of consciousness parameter ('BIS^TM')* and add the convenience of CNSystem's continuous non-invasive blood pressure monitoring ('CNAP')**. This addresses a growing requirement for non-invasive monitoring solutions that are more comprehensive and can effectively replace multiple single parameter monitors.

LiDCOview: an easy-to-use graphical display of historical LiDCOplusand LiDCOrapidhemodynamic data.

*BIS^TMand Bispectral Index are trademarks of Medtronic registered in the US and foreign countries.

**CNAP^TM is a trademark of CNSystems Medizintechnik AG.

LiDCO monitors use single-patient disposables (sensors or smartcards) and are also available in many markets as a software for service model all of which provide a recurring revenue stream.

LiDCO Distribution Network:

LiDCO sells directly to hospitals in the UK and USAand through a network of specialty critical care and anaesthesia distributors in the rest of the world.

LiDCO's headquarters are in London and its shares are traded on AIM.